Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,401 to 1,420 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineering γδ T Cells: Recognizing and Activating on Their Own Way. | Front Immunol | 2022 | 35603176 | PubTator, text mining | PubMed |
| Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. | Biomed Res Int | 2022 | 35601155 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies. | Front Oncol | 2022 | 35600381 | PubTator, text mining | PubMed |
| Antigen targeting to dendritic cells: Still a place in future immunotherapy? | Eur J Immunol | 2022 | 35598160 | PubTator, text mining | PubMed |
| mRNA-based therapeutics: powerful and versatile tools to combat diseases. | Signal Transduct Target Ther | 2022 | 35597779 | PubTator, text mining | PubMed |
| Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats. | Neurotoxicology | 2022 | 35594946 | PubTator, text mining | PubMed |
| Identifying tumor antigens and immuno-subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine. | Cancer Med | 2022 | 35593226 | PubTator, text mining | PubMed |
| A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma. | Biomed Res Int | 2022 | 35592520 | PubTator, text mining | PubMed |
| Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2. | Front Genet | 2022 | 35586565 | PubTator, text mining | PubMed |
| Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy. | Front Immunol | 2022 | 35585975 | PubTator, text mining | PubMed |
| CD70 CAR T cells in AML: Form follows function. | Cell Rep Med | 2022 | 35584621 | PubTator, text mining | PubMed |
| RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System. | Clin Cancer Res | 2022 | 35583609 | PubTator, text mining | PubMed |
| Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus Monkeys. | Toxicol Sci | 2022 | 35583313 | PubTator, text mining | PubMed |
| Mechanism underlying the immune checkpoint inhibitor-induced hyper-progressive state of cancer. | Cancer Drug Resist | 2022 | 35582541 | PubTator, text mining | PubMed |
| Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC. | Front Immunol | 2022 | 35572559 | PubTator, text mining | PubMed |
| The diverse role of oral fibroblasts in normal and disease. | J Oral Maxillofac Pathol | 2022 | 35571294 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates. | Front Genet | 2022 | 35571016 | PubTator, text mining | PubMed |
| Integrative analysis identifies CXCL11 as an immune-related prognostic biomarker correlated with cell proliferation and immune infiltration in multiple myeloma microenvironment. | Cancer Cell Int | 2022 | 35568859 | PubTator, text mining | PubMed |
| The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value. | J Clin Med | 2022 | 35566637 | PubTator, text mining | PubMed |
| Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma. | Cancers (Basel) | 2022 | 35565286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=71